Generic Name and Formulations:
Caprylic triglyceride, potassium caseinate (milk-derived protein), maltodextrin, whey protein (milk-derived), sugar, sunflower oil, dimagnesium phosphate, tricalcium phosphate, dipotassium phosphate, soy lecithin, distilled monoglyceride, silicon dioxide, natural vanilla bean extract, sucralose, acesulfame potassium; pwd; 40g per packet.
Indications for AXONA:
Dietary management of the metabolic processes associated with mild to moderate Alzheimer's disease.
1 packet once daily after meals; add contents of packet in 4–8oz of water or preferred liquids, mix thoroughly. May start with a graduated dosing regimen for 7 days before taking one full packet per day.
Milk or soy allergy.
Risk of ketoacidosis (eg, alcoholics, poorly controlled diabetics). History of GI inflammatory conditions (eg, IBS, diverticular disease, chronic gastritis, severe GERD). Renal dysfunction. Monitor triglyceride levels during therapy.
GI upset, flatulence, dyspepsia, dizziness, headache, increases in BUN, uric acid, or creatinine.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Computerized Training Programs for Schizophrenia Improve Cognitive Functioning
- Cognitive Behavioral Therapy May Alter Suicidal Ideation in Anxiety Disorders
- Antidepressant Effects of Ketamine Appear to Require Opioid System Activation
- Attention-Deficit/Hyperactivity Disorder Increasing Among US Children and Adolescents
- Cost-Effective Telehealth Alternatives for Veterans With Depression
- Polygenic Risk Scores Could Aid in Identifying Bipolar Disorder, Schizophrenia
- Brief Impression Questionnaire Useful in Schizophrenia Diagnoses